Structures by: Cobo J.
Total: 558
2-(4-(4-Methoxyphenyl)-3-methyl-1-phenylindeno[1,2-b]pyrazolo[4,3-e]pyridin-5(1H)-ylidene)malononitrile'
C30H19N5O
RSC Advances (2019) 9, 47 27318
a=14.878(7)Å b=12.149(6)Å c=27.262(12)Å
α=90° β=96.052(12)° γ=90°
(E)-3-benzoyl-2-methyl-4-(3-methylstyryl)quinoline
C26H21NO
Acta Crystallographica Section C (2020) 76, 9
a=13.2730(16)Å b=14.8012(16)Å c=20.137(2)Å
α=90° β=90° γ=90°
(E)-1-(2-Methyl-4-((E)-4-methylstyryl)quinolin-3-yl)-3- phenyl-prop-2-en-1-one
C28H23NO
Acta Crystallographica Section C (2020) 76, 9
a=10.8168(6)Å b=17.3361(10)Å c=12.8892(6)Å
α=90° β=114.132(2)° γ=90°
(<i>E</i>)-3-Acetyl-2-methyl-4-(4-methoxystyryl)quinoline
C21H19NO2
Acta Crystallographica Section C (2020) 76, 9
a=8.2595(4)Å b=6.4279(3)Å c=31.9064(14)Å
α=90° β=93.674(2)° γ=90°
(<i>E</i>)-3-Acetyl-4-(4-bromostyryl)-2-methylquinoline
C20H16BrNO
Acta Crystallographica Section C (2020) 76, 9
a=8.0849(3)Å b=6.6692(2)Å c=31.1063(10)Å
α=90° β=95.0050(10)° γ=90°
(<i>E</i>)-3-Acetyl-2-methyl-4-[4-(trifluoromethyl)styryl]quinoline
C21H16F3NO
Acta Crystallographica Section C (2020) 76, 9
a=8.0822(4)Å b=6.6567(4)Å c=32.1024(17)Å
α=90° β=90.576(2)° γ=90°
Ethyl (<i>E</i>)-2-methyl-4-(4-methoxystyryl)quinoline-3-carboxylate
C22H21NO3
Acta Crystallographica Section C (2020) 76, 9
a=9.5301(8)Å b=10.3513(8)Å c=10.3621(8)Å
α=65.374(3)° β=86.583(3)° γ=76.376(3)°
Ethyl (<i>E</i>)-2-methyl-4-[4-(trifluoromethyl)styryl]quinoline-3-carboxylate
C22H18F3NO2
Acta Crystallographica Section C (2020) 76, 9
a=8.7465(10)Å b=9.9436(11)Å c=11.1116(11)Å
α=105.446(4)° β=99.763(4)° γ=97.204(4)°
(3<i>RS</i>,1<i>SR</i>,2'<i>SR</i>,7a'<i>SR</i>)-2'-(4-Chlorophenyl)-1-\ benzyl-5-methyl-2''-sulfanylidene-5',6',7',7a'-tetrahydro-2'<i>H</i>-\ dispiro[indoline-3,3'-pyrrolizine-1',5''-thiazolidine]-2,4''-dione
C30H26ClN3O2S2
Acta Crystallographica Section C (2020) 76, 8
a=8.2419(2)Å b=28.0429(6)Å c=11.5843(3)Å
α=90° β=90° γ=90°
(3<i>RS</i>,1'<i>SR</i>,2'<i>SR</i>,7a'<i>SR</i>)-2'-(4-Chlorophenyl)-1-hexyl-2''-sulfanylidene-5',6',7',7a'-tetrahydro-2'<i>H</i>-dispiro[indoline-3,3'-pyrrolizine-1',5''-thiazolidine]-2,4''-dione
C28H30ClN3O2S2
Acta Crystallographica Section C (2020) 76, 8
a=14.1669(5)Å b=10.7145(3)Å c=17.1350(5)Å
α=90° β=98.6540(10)° γ=90°
1-Benzyl-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]indolin-2-one
C24H21NO4
Acta Crystallographica Section C (2020) 76, 5 433-445
a=18.7572(14)Å b=13.2095(10)Å c=16.750(2)Å
α=90° β=105.374(5)° γ=90°
1-Benzyl-3-{2-[4-(dimethylamino)phenyl]-2-oxoethyl}-3-hydroxyindolin-2-one
C25H24N2O3
Acta Crystallographica Section C (2020) 76, 5 433-445
a=9.1028(8)Å b=10.6434(9)Å c=11.2539(10)Å
α=88.988(3)° β=68.422(3)° γ=81.352(3)°
(<i>E</i>)-1-Benzyl-3-[2-(4-fluorophenyl)-2-oxoethylidene]indolin-2-one
C23H16FNO2
Acta Crystallographica Section C (2020) 76, 5 433-445
a=7.6021(6)Å b=20.4880(13)Å c=10.9319(7)Å
α=90° β=96.986(3)° γ=90°
1-Benzyl-3-hydroxy-3-[2-oxo-2-(pyridin-4-yl)ethyl]indolin-2-one
C22H18N2O3
Acta Crystallographica Section C (2020) 76, 5 433-445
a=7.8838(5)Å b=10.1766(8)Å c=11.8719(9)Å
α=87.554(3)° β=75.996(2)° γ=69.428(2)°
(<i>E</i>)-1-Benzyl-3-[2-oxo-2-(pyridin-4-yl)ethylidene]indolin-2-one
C22H16N2O2
Acta Crystallographica Section C (2020) 76, 5 433-445
a=7.3457(6)Å b=18.0675(16)Å c=13.1813(13)Å
α=90° β=105.994(3)° γ=90°
(<i>E</i>)-1-Benzyl-3-[2-(4-methoxyphenyl)-2-oxoethylidene]indolin-2-one
C24H19NO3
Acta Crystallographica Section C (2020) 76, 5 433-445
a=4.9743(2)Å b=29.1957(13)Å c=12.4406(6)Å
α=90° β=100.914(2)° γ=90°
(<i>E</i>)-1-Benzyl-3-[2-oxo-2-(thiophen-2-yl)ethylidene]indolin-2-one
C21H15NO2S
Acta Crystallographica Section C (2020) 76, 5 433-445
a=17.5058(14)Å b=8.8163(6)Å c=21.2092(16)Å
α=90° β=90° γ=90°
3-[2-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-2-oxoethyl]-1-benzyl-3-hydroxyindolin-2-one
C24H19NO5
Acta Crystallographica Section C (2020) 76, 5 433-445
a=11.8136(7)Å b=12.4987(10)Å c=13.5976(11)Å
α=93.084(3)° β=101.883(2)° γ=95.055(2)°
1-Phenylisochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C15H9N3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=11.6814(5)Å b=6.4310(3)Å c=16.0589(8)Å
α=90° β=100.687(2)° γ=90°
1-(2-Methylphenyl)isochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C16H11N3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=7.5676(5)Å b=20.2663(14)Å c=9.2503(7)Å
α=90° β=112.957(3)° γ=90°
1-(3-Chlorophenyl)isochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C15H8ClN3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=11.0993(8)Å b=12.8996(9)Å c=9.2234(6)Å
α=90° β=106.675(2)° γ=90°
(<i>E</i>)-1-Benzyl-5-chloro-3-[2-(4-chlorophenyl)-2-oxoethylidene]indolin-2-one
C23H15Cl2NO2
Acta Crystallographica Section C (2020) 76, 5 433-445
a=8.2010(6)Å b=9.7629(7)Å c=12.1740(9)Å
α=76.755(3)° β=87.675(3)° γ=76.211(3)°
1-(4-Chlorophenyl)isochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C15H8ClN3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=16.7331(12)Å b=5.9676(4)Å c=13.6810(10)Å
α=90° β=112.820(3)° γ=90°
Methyl 2-[4-hydroxy-1-(2-methylphenyl)-1<i>H</i>-1,2,3-triazol-5-yl]benzoate
C17H15N3O3
Acta Crystallographica Section C (2020) 76, 5 446-453
a=11.1518(5)Å b=9.3143(4)Å c=14.2417(6)Å
α=90° β=98.655(2)° γ=90°
<i>N</i>^4^-(2-Aminophenyl)-6-methoxy-5-nitrosopyrimidine-2,4-diamine
C25H22N6O
Acta Crystallographica Section C (2019) 75, 10
a=9.7167(10)Å b=16.1179(17)Å c=13.9936(16)Å
α=90° β=91.395(4)° γ=90°
6-Methoxy-<i>N</i>^5^-(4-methoxybenzyl)-4-[2-(4-methoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine
C27H26N6O3
Acta Crystallographica Section C (2019) 75, 10
a=15.8911(13)Å b=9.6209(7)Å c=15.9244(11)Å
α=90° β=91.581(3)° γ=90°
6-Methoxy-4-[2-(4-methylphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine monohydrate
C19H18N6O,H2O
Acta Crystallographica Section C (2019) 75, 10
a=8.1992(7)Å b=11.0160(8)Å c=11.4240(9)Å
α=109.105(3)° β=109.171(3)° γ=97.138(3)°
6-Methoxy-<i>N</i>^5^-(4-nitrobenzyl)-4-[2-(4-nitrophenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine
C25H20N8O5
Acta Crystallographica Section C (2019) 75, 10
a=7.6614(6)Å b=16.6048(11)Å c=18.1311(13)Å
α=90° β=97.101(3)° γ=90°
<i>N</i>-{2-Amino-6-methoxy-4-[2-(4-methylphenyl)-1<i>H</i>-\ benzo[<i>d</i>]imidazol-1-yl]pyrimidin-5-yl}-2,2,2-trifluoroacetamide
C21H17F3N6O2,CH4O
Acta Crystallographica Section C (2019) 75, 10
a=12.6296(8)Å b=11.2206(7)Å c=15.6480(10)Å
α=90° β=104.180(2)° γ=90°
<i>N</i>-{5-Amino-6-methoxy-6-[2-(4-methylphenyl)-1<i>H</i>-\ benzo[<i>d</i>]imidazol-1-yl]pyrimidin-2-yl}-2,2,2-trifluoroacetamide ethyl acetate monosolvate
C21H17F3N6O2,C4H8O2
Acta Crystallographica Section C (2019) 75, 10
a=9.1818(8)Å b=21.0771(16)Å c=13.3610(11)Å
α=90° β=91.777(3)° γ=90°
Ethyl 2-chloro-13-ethyl-4-oxo-8,13-dihydro-4<i>H</i>-benzo[5,6]azepino[3,2,1-<i>ij</i>]quinoline-5-carboxylate
C22H20ClNO3
Acta Crystallographica Section C (2017) 73, 1 28-35
a=6.8533(16)Å b=10.612(5)Å c=13.561(3)Å
α=72.45(4)° β=75.840(19)° γ=82.46(2)°
(9<i>RS</i>,15<i>RS</i>)-9-Ethyl-7,12-dimethyl-9,13b-dihydrodibenzo[<i>c</i>,<i>f</i>]thiazolo[3,2-<i>a</i>]azepin-3(2<i>H</i>)-one
C20H21NOS
Acta Crystallographica Section C (2017) 73, 1 28-35
a=18.1021(12)Å b=12.4436(8)Å c=14.8429(9)Å
α=90° β=97.645(3)° γ=90°
(9<i>RS</i>,15<i>RS</i>)-9-Ethyl-11-methyl-9,13b-dihydrodibenzo[<i>c</i>,<i>f</i>]thiazolo[3,2-<i>a</i>]azepin-3(2<i>H</i>)-one
C19H19NOS
Acta Crystallographica Section C (2017) 73, 1 28-35
a=11.4261(5)Å b=8.1847(3)Å c=16.8243(6)Å
α=90° β=93.067(2)° γ=90°
Methyl (<i>R</i>)-4-[(5<i>S</i>,8<i>R</i>,9<i>S</i>,10<i>R</i>,13<i>R</i>,14<i>S</i>,17<i>R</i>)-3-chloro-4-formyl-10,13-dimethyl-12-oxo-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-yl]pentanoate
C26H37ClO4
Acta Crystallographica Section C (2018) 74, 12
a=7.0444(3)Å b=10.8756(6)Å c=30.4910(14)Å
α=90° β=90° γ=90°
(5<i>S</i>,8<i>R</i>,9<i>S</i>,10<i>S</i>,13<i>S</i>,14<i>S</i>)-3-Chloro-10,13-dimethyl-17-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthrene-2-carbaldehyde
C20H27ClO2
Acta Crystallographica Section C (2018) 74, 12
a=12.984(2)Å b=6.2961(11)Å c=21.265(4)Å
α=90° β=94.306(5)° γ=90°
(5<i>S</i>,8<i>R</i>,9<i>S</i>,10<i>S</i>,13<i>R</i>,14<i>S</i>,17<i>R</i>)-3-Chloro-10,13-dimethyl-17-[(<i>R</i>)-6-methylheptan-2-yl)-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthrene-2-carbaldehyde
C28H45ClO
Acta Crystallographica Section C (2018) 74, 12
a=8.0097(6)Å b=14.8313(12)Å c=20.5873(15)Å
α=90° β=90° γ=90°
Methyl (2<i>RS</i>,4<i>SR</i>)-7-chloro-4-(2-chloroacetoxy)-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>b</i>]azepine-2-carboxylate
C14H15Cl2NO4
Acta Crystallographica Section C (2019) 75, 2
a=8.858(6)Å b=9.328(5)Å c=10.526(6)Å
α=96.039(18)° β=112.651(19)° γ=108.99(3)°
(4a<i>RS</i>,6<i>SR</i>)-9-Chloro-6-hydroxy-4a,5,6,7-tetrahydrobenzo[<i>f</i>][1,2,4]triazino[4,5-<i>a</i>]azepin-4(3<i>H</i>)-one
C12H12ClN3O2
Acta Crystallographica Section C (2019) 75, 2
a=5.595(4)Å b=8.377(5)Å c=12.712(8)Å
α=98.10(3)° β=100.10(2)° γ=101.76(3)°
(4a<i>RS</i>,6<i>SR</i>)-9-chloro-6-hydroxy-3-(2-hydroxyethyl)-2,3,4a,5,6,7-hexahydrobenzo[<i>f</i>]pyrazino[1,2-<i>a</i>]azepine-1,4-dione
C15H17ClN2O4
Acta Crystallographica Section C (2019) 75, 2
a=9.198(6)Å b=10.586(7)Å c=15.223(11)Å
α=90° β=105.56(2)° γ=90°
(3<i>RS</i>)-4-(2-Allyl-3,5-dimethylphenyl)-1-benzyl-3-phenylpiperazine-2,5-dione
C28H28N2O2
Acta Crystallographica Section C (2018) 74, 2
a=23.3641(8)Å b=10.0825(3)Å c=21.4524(7)Å
α=90° β=115.8850(10)° γ=90°
<i>N</i>,2,6,11-Tetramethyl-<i>N</i>-phenyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-4-amine
C22H24N4
Acta Crystallographica Section C (2018) 74, 3
a=11.2020(19)Å b=16.609(3)Å c=19.850(6)Å
α=90° β=90° γ=90°
5-Allyl-6-(1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-methyl-<i>N</i>-(4-methylphenyl)pyrimidin-4-amine
C22H21N5
Acta Crystallographica Section C (2018) 74, 3
a=9.425(2)Å b=11.184(3)Å c=17.321(6)Å
α=90° β=101.091(11)° γ=90°
6,7,9,11-Tetramethyl-4-(5-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C24H25N5
Acta Crystallographica Section C (2018) 74, 3
a=9.7866(13)Å b=10.2122(15)Å c=10.9551(14)Å
α=97.816(9)° β=112.433(8)° γ=94.149(8)°
<i>N</i>^4^-{2-[(Ethoxymethylidene)amino]phenyl}-6-methoxy-5-nitrosopyrimidine-2,4-diamine dimethyl sulfoxide monosolvate
C14H16N6O3,C2H6OS
Acta Crystallographica Section C (2018) 74, 6
a=10.8498(11)Å b=17.2238(15)Å c=11.3806(11)Å
α=90° β=115.351(3)° γ=90°
6-Methoxy-<i>N</i>^4^-{2-[(4-methylbenzylidene)amino]phenyl}-5-nitrosopyrimidine-2,4-diamine dimethyl sulfoxide monosolvate
C19H18N6O2,C2H6OS
Acta Crystallographica Section C (2018) 74, 6
a=10.801(5)Å b=17.301(8)Å c=11.777(7)Å
α=90° β=104.28(2)° γ=90°
(<i>RS</i>)-(<i>E</i>)-4-[2-(4-Chlorobenzylidene)hydrazinyl]-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C21H20ClN5
Acta Crystallographica Section C (2019) 75, 6
a=12.9010(15)Å b=20.055(3)Å c=8.7001(13)Å
α=90° β=123.161(7)° γ=90°
(<i>RS</i>)-(<i>E</i>)-4-[2-(4-Chlorobenzylidene)hydrazinyl]-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C21H20ClN5
Acta Crystallographica Section C (2019) 75, 6
a=8.8623(4)Å b=14.4656(7)Å c=14.2723(7)Å
α=90° β=90° γ=90°
Ethyl (<i>RS</i>)-13-ethyl-2-fluoro-4-oxo-8,13-dihydro-4<i>H</i>-benzo[5,6]azepino[3,2,1-<i>ij</i>]quinoline-5-carboxylate
C22H20FNO3
Acta Crystallographica Section C (2019) 75, 6
a=9.5920(6)Å b=13.4325(7)Å c=14.2186(8)Å
α=90° β=103.290(2)° γ=90°
(<i>RS</i>)-5-Acetyl-2-chloro-11-methyl-5,6,11,12-tetrahydrobenzo[<i>b</i>,<i>f</i>]azocine
C18H18ClNO
Acta Crystallographica Section C (2019) 75, 6
a=8.333(5)Å b=20.800(14)Å c=9.186(6)Å
α=90° β=107.857(17)° γ=90°
(6<i>RS</i>)-4-Chloro-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C14H14ClN3
Acta Crystallographica Section C (2015) 71, 12
a=8.6570(5)Å b=8.8622(17)Å c=9.0321(11)Å
α=92.649(13)° β=113.635(9)° γ=100.632(12)°
(6<i>RS</i>)-4-Chloro-8-methoxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C15H16ClN3O
Acta Crystallographica Section C (2015) 71, 12
a=8.2148(7)Å b=12.9078(8)Å c=15.0778(6)Å
α=90° β=122.774(5)° γ=90°
(6<i>RS</i>)-4-Chloro-8-hydroxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C14H14ClN3O
Acta Crystallographica Section C (2015) 71, 12
a=8.0251(7)Å b=21.5510(17)Å c=8.0709(6)Å
α=90° β=116.216(6)° γ=90°
(6<i>RS</i>)-4-Chloro-8-methoxy-6,11-dimethyl-2-phenyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C21H20ClN3O
Acta Crystallographica Section C (2015) 71, 12
a=13.9431(8)Å b=9.2078(10)Å c=14.802(4)Å
α=90° β=106.521(8)° γ=90°
6<i>H</i>-Spiro[pyrazolo[1,5-<i>c</i>]quinazoline-5,4'-thiochroman]
C18H15N3S
Acta Crystallographica Section C (2015) 71, 11
a=12.5223(8)Å b=7.6646(4)Å c=15.1729(13)Å
α=90° β=101.044(4)° γ=90°
(RS)-8-chloro-6-methyl-1,2,6,7-tetrahydropyrimido[5',4':6,7]azepino[3,2,1-hi]indole
C15H14ClN3
Acta Crystallographica Section C (2016) 72, 1 52-56
a=6.6250(3)Å b=22.4796(13)Å c=8.6355(4)Å
α=90° β=100.610(3)° γ=90°
(RS)-9-chloro-7-methyl-2,3,7,8-tetrahydro-1H-pyrimido[5',4':6,7]azepino[3,2,1-ij]-quinoline
C16H16ClN3
Acta Crystallographica Section C (2016) 72, 1 52-56
a=8.1840(10)Å b=9.5399(12)Å c=10.2185(19)Å
α=104.471(7)° β=101.049(6)° γ=111.324(5)°
(6<i>RS</i>,11<i>RS</i>)-11-Ethyl-6,11-dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>e</i>]azepine-6-carboxamide
C17H18N2O
Acta Crystallographica Section C (2016) 72, 7 549-554
a=5.6051(2)Å b=8.6411(3)Å c=14.3853(6)Å
α=86.192(2)° β=81.237(3)° γ=87.313(2)°
3-Acetyl-8-allyl-6-methyl-2-phenylquinolin-4-yl acetate
C23H21NO3
Acta Crystallographica Section C (2016) 72, 8
a=9.0386(9)Å b=8.2036(8)Å c=25.119(3)Å
α=90° β=96.385(10)° γ=90°
(2<i>RS</i>)-2,8-Dimethyl-4-phenyl-1,2-dihydro-6<i>H</i>-pyrrolo[3,2,1-<i>ij</i>]quinolin-6-one
C19H17NO
Acta Crystallographica Section C (2016) 72, 8
a=17.756(5)Å b=10.364(3)Å c=15.232(4)Å
α=90° β=92.774(8)° γ=90°
6,11-Dimethyl-3,5,6,11-tetrahydro-4<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-4-one
C14H15N3O
Acta Crystallographica Section C (2016) 72, 4 346-357
a=17.0839(16)Å b=4.2350(3)Å c=16.2258(18)Å
α=90° β=94.047(8)° γ=90°
4-Butoxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-8-ol
C18H23N3O2
Acta Crystallographica Section C (2016) 72, 4 346-357
a=11.4233(4)Å b=7.3707(3)Å c=20.4624(7)Å
α=90° β=93.561(2)° γ=90°
<i>N</i>-Benzyl-6-methyl-1,2,6,7-tetrahydropyrimido\ [5,4':6,7]azepino[3,2,1-<i>hi</i>]indol-8-amine
C22H22N4
Acta Crystallographica Section C (2016) 72, 4 346-357
a=7.7594(4)Å b=8.5383(6)Å c=13.4525(8)Å
α=90° β=100.483(3)° γ=90°
<i>N</i>-Benzyl-8-methoxy-6,11-dimethyl-6,11-dihydro-5<i>H</i>- benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-4-amine
C22H24N4O
Acta Crystallographica Section C (2016) 72, 4 346-357
a=12.2994(8)Å b=9.1501(5)Å c=16.1710(9)Å
α=90° β=95.289(2)° γ=90°
4-Dimethylamino-6,11-dimethyl-6,11-dihydro-5<i>H</i>-\ benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-8-ol
C16H20N4O
Acta Crystallographica Section C (2016) 72, 4 346-357
a=18.886(3)Å b=7.9898(15)Å c=19.335(3)Å
α=90° β=90° γ=90°
<i>N</i>-Benzyl-7-methyl-2,3,7,8-tetrahydro-1<i>H</i>-\ pyrimido[5,4':6,7]azepino[3,2,1-<i>ij</i>]quinolin-9-amine
C23H24N4
Acta Crystallographica Section C (2016) 72, 4 346-357
a=15.083(3)Å b=27.563(4)Å c=8.8681(13)Å
α=90° β=90° γ=90°
8-methyl-7-(4-chlorophenyl)-10-phenyl-6,10-dihydro- 5H-benzo[h]pyrazolo[3,4-b]quinoline
C27H20ClN3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=12.1072(4)Å b=14.2672(5)Å c=12.7635(4)Å
α=90.00° β=109.953(8)° γ=90.00°
8-methyl-7-(3-pyridinyl)-10-phenyl-6,10- dihydro-5H-benzo[h]pyrazolo[3,4-b]quinoline
C26H20N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.2274(6)Å b=13.7079(8)Å c=12.6935(7)Å
α=90.00° β=95.731(3)° γ=90.00°
11-(3,4,5-trimethoxyphenyl)-10-methyl-8-phenyl-6,8- dihydro-5H-benzo[f]pyrazolo[3,4-b]quinoline
C30H27N3O3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=10.4716(9)Å b=20.0027(18)Å c=12.1529(9)Å
α=90.00° β=107.818(4)° γ=90.00°
8-methyl-7-(4-pyridinyl)-10-phenyl-10H- benzo[h]pyrazolo[3,4-b]quinoline
C26H18N4
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.3560(3)Å b=17.3507(5)Å c=9.7577(2)Å
α=90.00° β=97.262(2)° γ=90.00°
11-(4-methoxyphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3O
Acta Crystallographica Section B (2008) 64, 1 72-83
a=18.0854(3)Å b=21.2296(5)Å c=23.8007(5)Å
α=90.00° β=108.2580(10)° γ=90.00°
11-(4-methylphenyl)-10-methyl-8-phenyl-6,8-dihydro- 5H-benzo[f]pyrazolo[3,4-b]quinoline
C28H23N3
Acta Crystallographica Section B (2008) 64, 1 72-83
a=11.1334(3)Å b=11.4672(2)Å c=17.6270(4)Å
α=97.858(2)° β=106.135(3)° γ=97.496(2)°
N^4^-(Cyclohexyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H18N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=11.2407(10)Å b=7.3654(5)Å c=15.8178(12)Å
α=90.00° β=106.005(7)° γ=90.00°
N^4^-Methyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
C12H12N6
Acta Crystallographica Section B (2008) 64, 5 610-622
a=10.6661(12)Å b=7.7279(9)Å c=14.359(2)Å
α=90.00° β=100.071(7)° γ=90.00°
2-[4-(6-Amino-1H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]ethanol
C11H17N7O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.0297(9)Å b=13.859(3)Å c=25.766(6)Å
α=90.00° β=90.00° γ=90.00°
N^4^-(4-Methoxyphenyl)-N^4^-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
2(C13H14N6O),H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=8.9516(5)Å b=12.0627(7)Å c=12.9053(7)Å
α=91.612(4)° β=92.065(3)° γ=95.259(5)°
C11H15ClN4O
C11H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=5.907(2)Å b=10.398(3)Å c=10.801(2)Å
α=110.86(3)° β=94.19(2)° γ=96.00(3)°
(4-(Pyrrolidin-1-yl)-1/H/-pyrazolo[3,4-/d/]pyrimidin-6-amine) ethanol hemisolvate hemihydrate
2(C9H12N6),C2H6O,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.9342(15)Å b=8.9219(19)Å c=16.767(3)Å
α=76.855(16)° β=83.505(14)° γ=88.003(17)°
C9H13ClN4O
C9H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=11.328(3)Å b=8.0810(4)Å c=11.3849(12)Å
α=90.00° β=98.709(14)° γ=90.00°
C9H11ClN4O2
C9H11ClN4O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.3540(5)Å b=8.2910(13)Å c=17.276(3)Å
α=90.00° β=97.962(9)° γ=90.00°
C12H17ClN4O
C12H17ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.5722(6)Å b=8.7195(5)Å c=8.7681(7)Å
α=82.598(6)° β=82.701(5)° γ=88.645(5)°
C14H15ClN4O
C14H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.9897(5)Å b=8.0922(4)Å c=11.2786(7)Å
α=91.602(4)° β=107.220(5)° γ=91.776(5)°
C13H13ClN4O
C13H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.1811(12)Å b=8.8325(10)Å c=9.3356(6)Å
α=81.844(9)° β=82.015(10)° γ=73.041(7)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.0568(7)Å b=8.211(2)Å c=10.565(3)Å
α=84.590(16)° β=82.363(14)° γ=78.687(14)°
C12H11ClN4O
C12H11ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.9938(6)Å b=7.9544(10)Å c=10.7507(14)Å
α=81.191(11)° β=82.469(12)° γ=87.333(10)°
C15H12ClN5O
C15H12ClN5O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.5716(7)Å b=16.6432(18)Å c=10.9450(7)Å
α=90.00° β=93.549(6)° γ=90.00°
C18H15ClN4O
C18H15ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=6.5520(11)Å b=11.1012(7)Å c=11.4111(4)Å
α=79.958(5)° β=84.802(9)° γ=77.009(9)°
C11H16ClN5O2
C11H16ClN5O2
Acta Crystallographica Section B (2008) 64, 5 596-609
a=7.2147(6)Å b=8.8563(10)Å c=10.2855(12)Å
α=84.856(10)° β=85.296(10)° γ=79.092(7)°
C10H13ClN4O
C10H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=14.4681(17)Å b=11.1378(17)Å c=7.4534(7)Å
α=90.00° β=116.535(7)° γ=90.00°
N^4^-Methyl-N^4^-(4-phenylmethyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine monohydrate
C13H14N6,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=16.5577(12)Å b=8.6833(3)Å c=18.4640(13)Å
α=90.00° β=90.00° γ=90.00°
N^4^-Ethyl-N^4^-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine hemihydrate
C13H14N6,0.5(H2O)
Acta Crystallographica Section B (2008) 64, 5 610-622
a=17.642(3)Å b=18.278(3)Å c=8.3034(18)Å
α=90.00° β=103.512(17)° γ=90.00°
(1<i>RS</i>,2'<i>RS</i>,3<i>SR</i>,7a'<i>SR</i>)-2'-Benzoyl-1-hexyl-2-oxo-\ 1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizine]-1'-carboxylic acid
C28H32N2O4
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1109-1115
a=19.9182(9)Å b=19.9182(9)Å c=19.9182(9)Å
α=116.980(2)° β=116.980(2)° γ=116.980(2)°
(1'<i>RS</i>,2'<i>RS</i>,3<i>SR</i>,7a'<i>SR</i>)-1',2'-Bis(4-chlorobenzoyl)-5,7-dichloro-2-oxo-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizine] dichloromethane 0.981-solvate
C28H20Cl4N2O3,0.981(CH2Cl2)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1109-1115
a=12.800(4)Å b=12.511(5)Å c=18.638(5)Å
α=90° β=99.325(12)° γ=90°
(<i>E</i>)-3-(2-Bromophenyl)-2-(1-methyl-1<i>H</i>-indole-3-carbonyl)acrylonitrile
C19H13BrN2O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=9.188(5)Å b=9.308(5)Å c=10.887(5)Å
α=113.56(2)° β=90.782(18)° γ=116.173(16)°
(2<i>RS</i>)-2-(2-Bromobenzyl)-3-(1-methyl-1<i>H</i>-indol-3-yl)-\ 3-oxopropanenitrile
C19H15BrN2O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=13.728(6)Å b=14.901(6)Å c=15.507(6)Å
α=90° β=92.165(19)° γ=90°
(<i>E</i>)-1-(1-Acetyl-1<i>H</i>-indol-3-yl)-3-(2-bromophenyl)-2-cyanoprop-1-en-1-yl acetate
C22H17BrN2O3
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=19.406(9)Å b=8.773(4)Å c=23.028(9)Å
α=90° β=103.318(15)° γ=90°
(2<i>RS</i>)-3-(1-benzyl-1<i>H</i>-indol-3-yl)-\ 2-(2-bromobenzyl)-3-oxopropanenitrile
C25H19BrN2O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=10.912(4)Å b=12.544(8)Å c=15.583(7)Å
α=89.23(4)° β=79.49(3)° γ=73.20(3)°
2-Benzoyl-3-(2-bromophenyl)acrylonitrile
C16H10BrNO
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=10.986(4)Å b=8.977(4)Å c=13.209(5)Å
α=90° β=97.140(17)° γ=90°
(<i>E</i>)-1-(1-Benzyl-1<i>H</i>-indol-3-yl)-3-(2-bromophenyl)-2-cyanoprop-1-en-1-yl benzoate
C32H23BrN2O2
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=14.886(4)Å b=8.129(3)Å c=21.432(6)Å
α=90° β=104.638(12)° γ=90°
(<i>E</i>)-3-{5-[Benzyl(methyl)amino]-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl}-1-(4-bromophenyl)prop-2-en-1-one
C27H24BrN3O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 784-790
a=31.172(16)Å b=10.039(6)Å c=17.861(10)Å
α=90° β=123.334(14)° γ=90°
5-[Benzyl(methyl)amino]-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C19H19N3O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 784-790
a=7.811(4)Å b=17.951(9)Å c=11.405(6)Å
α=90° β=92.36(2)° γ=90°